Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

PHAXIAM TherapeuticsPHAXIAM Therapeutics
VS
RegeneronRegeneron
PHAXIAM Therapeutics

PHAXIAM Therapeutics

60 avenue Rockefeller, Bâtiment Bioserra, LYON, Rhône-Alpes, FR, 69008

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://www.phaxiam.com
754/1000Fair

PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses...

NAICS:N/A
NAICS Definition:Others
Employees:61
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Regeneron

Regeneron

777 Old Saw Mill River Road, Tarrytown, 10591, US

Last Update: 21/06/2026

View Profile
Between 800 and 849
http://www.regeneron.com
818/1000Good

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new w...

NAICS:N/A
NAICS Definition:Others
Employees:16,502
Subsidiaries:2
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
PHAXIAM Therapeutics

PHAXIAM Therapeutics

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Regeneron

Regeneron

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for PHAXIAM Therapeutics in 2026.

Incidents

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for Regeneron in 2026.

Incidents

Incident History - PHAXIAM Therapeutics (X = Date, Y = Severity)

PHAXIAM Therapeutics cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Regeneron (X = Date, Y = Severity)

Regeneron cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
PHAXIAM Therapeutics

PHAXIAM Therapeutics

Incidents
No explicit notable incidents reported.
Regeneron

Regeneron

Incidents
No explicit notable incidents reported.

FAQ

Between PHAXIAM Therapeutics company and Regeneron company, which one has the best AI Cybersecurity Score ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has experienced more cyber incidents in the past ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has experienced more cyber incidents this year ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has experienced at least one ransomware attack ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has experienced at least one data breach ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has experienced at least one targeted cyberattack ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has experienced at least one vulnerability ?
Between PHAXIAM Therapeutics company and Regeneron company, which one holds the most compliance certifications ?
Between PHAXIAM Therapeutics company and Regeneron company, which one holds the fewest compliance certifications ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has the most subsidiaries ?
Between PHAXIAM Therapeutics company and Regeneron company, which one has the largest number of employees ?
Between PHAXIAM Therapeutics and Regeneron, which company holds both SOC 2 Type 1 certifications ?
Between PHAXIAM Therapeutics and Regeneron, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - PHAXIAM Therapeutics or Regeneron ?
Which company is PCI DSS compliant - PHAXIAM Therapeutics or Regeneron ?
Between PHAXIAM Therapeutics and Regeneron, which company complies with HIPAA regulations for healthcare data ?
Between PHAXIAM Therapeutics and Regeneron, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-83524
SUMMARY

A security vulnerability has been detected in RedPort Optimizer wXa-203, Optimizer wXa-213 and Optimizer wXa-223 up to 20260704. This impacts the function exec of the file /xgatev1/system/datetime.php of the component System Clock. The manipulation leads to command injection. The attack may be initiated remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-31
UPDATED
Date2026-08-31
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-82971
SUMMARY

A vulnerability was determined in QVidium Opera11 3.3.2a26-Ax4x-opera11. This affects an unknown part of the file /cgi-bin/net_tr.cgi of the component CGI Script. This manipulation of the argument ipaddr causes command injection. The attack may be initiated remotely. The exploit has been publicly disclosed and may be utilized. The vendor explains: "QVidium has now closed its doors and no longer will be able to sell products or provide support." This vulnerability only affects products that are no longer supported by the maintainer.

PUBLISHED
Date2026-08-31
UPDATED
Date2026-08-31
RISK INFORMATION (Score: 10)
CVSS2
Base Score: 10.0
Complexity: LOW
AV:N/AC:L/Au:N/C:C/I:C/A:C
CVSS3
Base Score: 10.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.9
CVE-2026-82957
SUMMARY

A vulnerability was found in hyperledger-firefly firefly up to 1.4.0. The impacted element is the function ValidateOptions of the file internal/events/webhooks/webhooks.go of the component Webhook Subscription. Performing a manipulation of the argument url results in server-side request forgery. Remote exploitation of the attack is possible. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-31
UPDATED
Date2026-08-31
RISK INFORMATION (Score: 7.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 7.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
3.9
CVE-2026-82954
SUMMARY

A vulnerability was detected in Dokploy up to 0.29.7. This issue affects the function writeTraefikConfigInPath of the file packages/server/src/utils/traefik/application.ts of the component Settings. The manipulation of the argument path results in path traversal. The attack can be launched remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-31
UPDATED
Date2026-08-31
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-82922
SUMMARY

A security vulnerability has been detected in ShopEx ECShop up to 2.5.1. This vulnerability affects the function flow_update_cart of the file /flow.php?step=update_cart. The manipulation of the argument rec_id leads to sql injection. The attack can be initiated remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-31
UPDATED
Date2026-08-31
RISK INFORMATION (Score: 7.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 7.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
3.9